Community Why Do I Pheel This Way? Episode 3: Finding Strength Through Sports While Living with Phenylketonuria June 25, 2026
Community Why Do I Pheel This Way? Episode 3: Finding Strength Through Sports While Living with Phenylketonuria June 25, 2026
Community Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria June 11, 2026
Community People and Culture Kim Warner Builds Pathways for Early-Career Professionals Seeking Mission-Driven Opportunities May 29, 2026
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome July 27, 2026
U.S. Food and Drug Administration Accepts BioMarin’s Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia July 13, 2026
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026 June 16, 2026
BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia May 20, 2026
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency May 18, 2026